This inventor holds 18 USPTO granted patents, plus 4 CIPO patents and 1 EPO patent. Top assignee: Bionumerik Pharmaceuticals, Inc.. Active years: 1998-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2001
Title: Inventor Dhanabalan Murali: Pioneering Cancer Treatment Innovations
Introduction
Dhanabalan Murali is a distinguished inventor based in San Antonio, Texas, known for his significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With an impressive portfolio of 18 patents, his innovative work focuses on creating novel compounds that have the potential to revolutionize cancer therapies.
Latest Patents
Murali's recent innovations include highly lipophilic camptothecin derivatives, which relate to novel derivatives of camptothecin with specific substitutions that enhance their efficacy as Topoisomerase I inhibitors. This invention aims to provide new treatment options for patients battling cancer. Additionally, he holds a patent for pharmaceutical formulations of taxanes, including paclitaxel and docetaxel, which are crucial antineoplastic agents for cancer treatment. These formulations are tailored to enhance the delivery and effectiveness of these drugs in clinical settings.
Career Highlights
Currently, Dhanabalan Murali is associated with Bionumerik Pharmaceuticals, a company that underscores his commitment to advancing pharmaceutical research and development. His work is characterized by a focus on innovative formulations that address complex medical challenges associated with cancer treatments.
Collaborations
Murali collaborates with talented colleagues like Kochat Haridas and Dasharatha Gauravaram Reddy, contributing to a dynamic team that fosters innovation in drug development and pharmaceutical research.
Conclusion
With a total of 18 patents, Dhanabalan Murali stands out as an influential figure in pharmaceutical inventions, particularly in the realm of cancer therapeutics. His groundbreaking work not only highlights his ingenuity as an inventor but also promises advancements that could significantly improve patient outcomes in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile